Dr. José Francisco Flores Martín is an expert in minimally invasive urological surgery, with extensive experience in endoscopic, percutaneous, and laser techniques for the treatment of urinary stones and tumors of the urinary tract. He also specializes in the advanced diagnosis of prostate cancer.
Dr. José Francisco Flores Martín

Dr. José Francisco Flores Martín is a urologist with a degree in Medicine from the Miguel Hernández University of Elche. He completed his residency in Urology between 2010 and 2015 at the Virgen de las Nieves University Hospital in Granada. He has a strong academic background, including a PhD in Biomedicine from the University of Granada, awarded with the highest distinction, and several master's degrees in Functional Urology, Renal Cancer, and Prostate Cancer from the University of Salamanca. He has been a Fellow of the European Board of Urology (FEBU) since 2015 and has specialized training in laparoscopic and advanced urological surgery.
Current specialization
The doctor is an expert in minimally invasive, endoscopic, percutaneous, and laser surgery for the treatment of urinary stones and tumors of the upper and lower urinary tract. He is also an expert in advanced techniques for diagnosing prostate cancer.
Academic activities and membership in organizations
Dr. Flores has been a member of the Andalusian Association of Urology (AAU) since 2012, as well as the Spanish Association of Urology (AEU). He actively participates in research as a member of the IBS A-08 Research Group “Immune Response and Cancer. Mechanisms of Escape from the Immune Response” at the Granada Institute for Biomedical Research. In addition, since 2020, he has collaborated as a scientific reviewer for the journal Spanish Archives of Urology.
Scientific activity
Participation in Clinical Trials: Public and Private Calls for Proposals
- Collaborating Researcher: Title: Study of candidate genes in prostate cancer. A new treatment strategy.
- Participation as a Collaborating Investigator (CI) in the study: “ENCORE-01. Assessment of progression-free survival in patients diagnosed with high-risk non-muscle-invasive bladder cancer (NMIBC) treated with adjuvant IMUNO BCG Moreau RJ”. Sponsor: FIU and Biofabri SL. EUDRACT No.: 2017-002928-24
- Participation as a Collaborating Investigator (CI) in the study: HLA class I in metastatic progression and resistance to new generation immunotherapy: Implications in cancer immune escape. Carlos III Health Institute. 2014-2017.
- Participation as a Collaborating Investigator (CI) in the Observational Study on the management in clinical practice of castration-resistant prostate cancer with unknown metastatic status: AFRODITA Study
Awards:
- First prize for best oral presentation: The combination of HLA-I positivity and PD-L1 negativity in tumor cells provides an immune rejection mechanism in bladder cancer. José Francisco Flores-Martín et al. Andalusian Congress of Urology 2019.
- 3 rd price for best original paper in 2016 during the XXXIX Edition of Pérez Castro Price of the Journal Archivos Españoles de Urología for “Cold ischemia time and graft survival A paired analysis. Arch. Esp. Urol. 2016; 69 (3): 121-127.
- Best Poster during the XXVIIIth Congress of the Andalusian Association of Urology. Jerez de la Frontera. 15-16th October 2015. Title: How many patients meet CHAARTED criteria in our routine clinical practice during a year?”
Scientific production:
Press here to learn about their scientific output
Finally, Dr. Flores has developed a distinguished scientific career, serving as lead author or co-author on more than ten book chapters. He has presented over ten papers at international conferences, more than thirty at national conferences, and just as many at regional conferences, consistently ranking among the top three authors.























